How Serious Is an Aerococcus urinae Infection?

Most Aerococcus urinae infections are urinary tract infections that respond well to common antibiotics, but in the wrong host the same bacterium can enter the bloodstream and cause endocarditis, sepsis, or death. Mortality from A. urinae bloodstream infections runs in the range of 17 to 24 percent within three months, and endocarditis caused by this organism carries a mortality rate around 26.5 percent. The gap between “annoying UTI” and “life-threatening systemic infection” is mostly determined by the patient’s age, sex, and underlying health conditions, along with whether the lab catches the organism in the first place.

Who Gets These Infections

A. urinae overwhelmingly targets older adults with existing urologic problems. A nationwide Swedish case-control study of aerococcal bloodstream infections found a median patient age of 82, and nearly 79 percent of cases were men. The age-stratified incidence was effectively zero in people under 60, then climbed sharply, peaking in men aged 90 to 94.¹ That same study found that structural urologic conditions more than doubled the adjusted odds of a bloodstream infection.

The list of predisposing factors reads like a chart of common conditions in elderly men: benign prostatic hyperplasia, urinary retention, indwelling catheters, bladder or prostate cancer, diabetes, chronic kidney disease, and heart disease.² Neurologic conditions that impair bladder emptying also showed up as a strong risk factor in the Swedish data, with nearly 40 percent of bloodstream-infection patients having a neurological diagnosis compared with about 14 percent of controls.¹

Whether the organism truly favors men or simply gets caught more often in men remains debated. Some authors argue both sexes are affected equally when it comes to simple UTIs, but men appear to be at clearly greater risk for the severe downstream complications like bacteremia and endocarditis.² Meanwhile, A. urinae has also been isolated from women with lower urinary tract symptoms including urgency incontinence and overactive bladder, which suggests the bacterium may live in or around the urinary tract more commonly than older literature recognized.³

When a UTI Turns Dangerous

The serious concern with A. urinae is not the UTI itself but what happens if the bacterium crosses into the bloodstream. A. urinae rarely causes severe infections, but when it does, the consequences can be devastating. In one case series of 16 patients with A. urinae bacteremia, nine met the criteria for severe sepsis and four more met the criteria for sepsis. All but one patient were men over 70 with underlying urologic conditions.⁴

An unsettling detail from that study: urine cultures were frequently negative in patients whose blood cultures grew A. urinae. Separate case descriptions have confirmed the same pattern, with blood cultures turning positive while urine showed nothing.⁵ This means a patient can have a urinary source of infection that the standard urine workup does not detect, which complicates the clinical picture and can delay appropriate treatment.

Endocarditis, an infection of the heart valves, is the most feared complication. A review of 68 reported cases of A. urinae endocarditis found that roughly a third of patients developed septic embolization, with the brain being the most common site. The mortality rate in that case series was about 26.5 percent.⁶ For context, that is comparable to or slightly worse than the death rate seen in endocarditis caused by more familiar organisms. Looking at A. urinae bacteremia more broadly (not just endocarditis cases), the 30-day all-cause mortality was about 17 percent and the 3-month mortality about 24 percent.⁷ A separate estimate from population-level data in Scandinavia put the mortality from A. urinae bacteremia at roughly 22 percent.⁸

Why This Bacterium Gets Missed

Part of what makes A. urinae infections tricky is that the organism is easy to misidentify. Under the microscope it looks a lot like streptococci, enterococci, or staphylococci, and the commercial identification systems that many labs rely on historically did not include A. urinae in their databases.⁹ A culture might come back labeled as an enterococcus or a viridans streptococcus, and the clinician would treat accordingly, never knowing the real culprit.

The adoption of a newer identification technology, MALDI-TOF mass spectrometry, has changed the picture considerably. This technique identifies bacteria by their protein fingerprint rather than by biochemical reactions, and it correctly identifies aerococci to the species level with high accuracy.¹⁰ Since labs began adopting MALDI-TOF, the reported incidence of A. urinae infections has risen, not because the infections are new but because they are finally being recognized.¹¹ This is an “emerging pathogen” not because it recently evolved but because the diagnostic tools caught up.

The practical takeaway is that in hospitals and clinics still using older biochemical identification methods, an A. urinae infection may go unrecognized. If you or a family member is an elderly adult with urologic problems and a UTI that does not respond as expected to treatment, it is worth asking whether the lab used a modern identification platform.

Treatment and Antibiotic Options

The good news is that A. urinae is broadly susceptible to many common antibiotics. In vitro testing of clinical isolates shows low resistance to penicillin, amoxicillin, ceftriaxone, doxycycline, vancomycin, linezolid, meropenem, and trimethoprim-sulfamethoxazole.¹² For a straightforward UTI, oral amoxicillin or another penicillin-class drug typically works well.

There are some gaps in the susceptibility profile worth knowing about. More than half of isolates in one large study showed elevated resistance to clindamycin, about 44 percent showed resistance to erythromycin, and roughly 16 percent had reduced susceptibility to levofloxacin (a fluoroquinolone).¹² Since fluoroquinolones are commonly prescribed for UTIs, this matters. If the lab has misidentified the bacterium as an enterococcus or streptococcus, the chosen antibiotic might miss the mark.

For severe infections like endocarditis, treatment typically involves intravenous penicillin or ceftriaxone combined with gentamicin. That combination has been shown to be bactericidal and synergistic against A. urinae isolates in laboratory testing.¹³ Endocarditis generally requires weeks of intravenous antibiotics and, in some patients, surgical valve repair or replacement.

One underappreciated challenge on the laboratory side is that even susceptibility testing itself can be unreliable for A. urinae. The organism is finicky about growth media. In one study, nearly 15 percent of A. urinae isolates failed to grow in standard supplemented broth after 44 hours, and growth varied significantly depending on the brand of media used.¹⁴ Standard gradient diffusion methods may also miss resistant strains.¹⁵ This means that even when the bug is correctly identified, the antibiotic susceptibility report the clinician receives may not be perfectly reliable, especially for borderline-resistant isolates.

Complications Beyond the Heart

Endocarditis and sepsis get most of the attention, but A. urinae has also been linked to bone and joint infections. Spondylodiscitis, an infection of the spinal vertebrae and the discs between them, is rare but has been reported. As of one recent review, only nine cases existed in the published literature. Seven of those patients were men, six were over 65, and underlying urologic conditions or diabetes were common.⁸ In those cases, bone biopsies reliably grew A. urinae even when urine cultures were negative, echoing the same diagnostic blind spot seen in bacteremia cases.

These skeletal infections can present with back pain and fever in a patient who may have had a recent or ongoing UTI, and suspicion of an unusual organism like A. urinae depends heavily on having the right laboratory tools and a clinical team that considers it in the differential diagnosis.

How A. urinae Causes Heart Valve Damage

Researchers have studied why this seemingly humble urinary bacterium has a particular affinity for heart valves. Laboratory work shows that A. urinae isolates from human blood can form biofilms, which are sticky microbial communities that are difficult for the immune system and antibiotics to penetrate. The presence of human plasma in the environment actually enhanced biofilm formation. Most of the tested isolates also triggered platelet aggregation, a process where blood platelets clump together around the bacteria. This clumping depends on plasma proteins at the bacterial surface, including fibrinogen and immunoglobulin G, and on active signaling within the platelets themselves.¹⁶

In plain terms, once A. urinae reaches the bloodstream, it can coat itself in blood proteins, recruit platelets into a growing clump, and embed itself in a biofilm on the heart valve surface. This is the same general strategy used by other bacteria that cause endocarditis. Genomic analysis has identified genes in A. urinae that are similar to known virulence genes in other pathogens, particularly genes involved in sticking to host tissues.¹⁷ The bacterium also has multiple types of capsular gene clusters, which may help it evade the immune system. Variation in these capsular gene clusters across different A. urinae strains might partly explain why some infections stay confined to the urinary tract while others progress to systemic disease.

Infections in Children

Nearly everything written about A. urinae focuses on elderly adults, and for good reason, since the vast majority of infections occur in that group. But pediatric cases do exist, and they deserve separate attention because they carry different implications. A case series examining A. urinae detection in children found that, beyond foul-smelling urine, the bacterium was associated with genuine UTIs. Underlying urogenital disorders were common in these children, prompting the authors to recommend that any child with A. urinae in their urine should be investigated for structural kidney or urinary tract abnormalities.¹⁸

Severe pediatric cases are exceptionally rare. One published report described what the authors believed to be the first case of an adolescent developing endocarditis caused by A. urinae.¹⁹ Its rarity in young people makes it easy to overlook entirely, but when a child has recurrent UTIs with unusual organisms or unexplained foul-smelling urine, A. urinae should be on the list of possibilities.

When A. urinae Shows Up in a Urine Culture and You Are Not Elderly

If you are a younger or middle-aged adult and a urine culture returns positive for A. urinae, the clinical picture is different from the elderly scenario described above. The Swedish population data showed that bloodstream infections from aerococci were essentially nonexistent in people under 60.¹ For a generally healthy person without urologic abnormalities, an A. urinae UTI is likely to behave like any other uncomplicated UTI and respond to a standard antibiotic course. The risk of it progressing to something dangerous is low.

That said, the finding should still be taken seriously as an accurate culture result, not dismissed as contamination. The growing recognition that A. urinae can be associated with lower urinary tract symptoms in women of various ages suggests it may be a legitimate pathogen in populations beyond the textbook elderly male profile.³ If symptoms persist after treatment, or if the same organism keeps appearing in cultures, it is worth discussing further workup with your doctor to rule out structural urinary tract issues.

A Related Organism Worth Knowing About

A. urinae is not the only Aerococcus species causing trouble. Its close relative Aerococcus sanguinicola also causes UTIs, bloodstream infections, and endocarditis, and the two species are frequently discussed together in the clinical literature.¹⁷ However, A. sanguinicola strains are genetically more uniform than A. urinae strains, which show marked diversity in genome size, gene content, and capsular gene organization. This genetic variability within A. urinae may be part of why the clinical spectrum of disease is so broad, ranging from harmless colonization to fatal endocarditis. Both species share the same problem of historical underdiagnosis, and both benefit from the improved detection that MALDI-TOF provides. In the Swedish bloodstream-infection data, A. urinae accounted for roughly 72 percent of aerococcal cases, with other species making up the remainder.¹

1
Emerging Infectious Diseases. Nationwide Observational Case–Control Study of Risk Factors for Aerococcus Bloodstream Infections, Sweden
2
PubMed Central. A Case Report of Aerococcus urinae Urinary Tract Infection in an Elderly Male with Multimorbidity
3
Journal of Bacteriology. Aerococcus urinae isolated from women with lower urinary tract symptoms: In vitro aggregation and genome analysis
4
PubMed. Clinical and microbiological features of bacteraemia with Aerococcus urinae
5
PubMed Central. Aerococcus urinae: severe and fatal bloodstream infections and endocarditis
6
PubMed Central. Endocarditis caused by Aerococcus urinae: a case report and review of literature
7
PubMed. Management and treatment of Aerococcus bacteremia and endocarditis
8
PubMed Central. Aerococcus urinae Spondylodiscitis: A Case Report and Review of the Literature
9
PubMed Central. Aerococcus urinae in urinary tract infections
10
PubMed Central. Matrix-assisted laser desorption ionization-time of flight mass spectrometry is a sensitive and specific method for identification of aerococci
11
Microbiologia Medica. The clinical relevance of pathogen Aerococcus urinae identification by MALDI-TOF mass spectrometry: a case of sepsis in 86-year-old Caucasian male
12
PubMed Central. In vitro antimicrobial susceptibility of Aerococcus urinae
13
PubMed. Bactericidal activity of penicillin, ceftriaxone, gentamicin and daptomycin alone and in combination against Aerococcus urinae
14
PubMed Central. Development of disk diffusion susceptibility test methods for Aerococcus spp. and updates to Clinical and Laboratory Standards Institute MIC breakpoints
15
PubMed. Evaluation of gradient diffusion in vitro susceptibility testing of Aerococcus urinae
16
PubMed Central. Platelet activation and biofilm formation by Aerococcus urinae, an endocarditis-causing pathogen
17
PubMed. Genomic characterization, phylogenetic analysis, and identification of virulence factors in Aerococcus sanguinicola and Aerococcus urinae strains isolated from infection episodes
18
PubMed Central. Aerococcus urinae — significance of detection in the paediatric urinary tract: a case series
19
The Pediatric Infectious Disease Journal. Aerococcus urinae as the Causative Agent in Infective Endocarditis of the Aortic Valve in a Pediatric Patient